RAPID MICRO BIOSYSTEMS, INC.
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Nov 5, 2026 (10 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 29, 2026 | Roth Capital | initiate | — → Buy | — | 53% |
| May 29, 2026 | Keybanc | maintain | Overweight → Overweight | — | 52% |
| May 22, 2026 | Lake Street | maintain | Buy → Buy | — | 47% |
| Jul 28, 2025 | Lake Street | initiate | — → Buy | $8 | 47% |
| Feb 12, 2025 | Keybanc | initiate | — → Overweight | $8 | 52% |
| Mar 7, 2023 | Morgan Stanley | reiterate | — → Equal-Weight | $2.75 | 54% |
| Aug 16, 2022 | JP Morgan | downgrade | Overweight → Neutral | $0 | 55% |
| May 11, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $8 | 54% |
| Mar 7, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $10 | 54% |
| Feb 15, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $11 | 54% |
| Nov 15, 2021 | Morgan Stanley | maintain | — → Equal-Weight | $24 | 54% |
| Aug 9, 2021 | Cowen & Co. | initiate | — → Outperform | $0 | — |
| Aug 9, 2021 | Morgan Stanley | initiate | — → Equal-Weight | $26 | 54% |
| Aug 9, 2021 | Stifel | initiate | — → Buy | $28 | 53% |
| Aug 9, 2021 | JP Morgan | initiate | — → Overweight | $30 | 55% |
No cross-platform signals in the last 90 days